Showing 451-460 of 1328 results for "".
Neuromuscular Notes: Genetic Testing for Neuromuscular Diseases
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-genetic-testing-for-neuromuscular-diseases/32181/This review presents a discussion on best practices for the clinical workup of suspected genetic neuromuscular diseases and provides an overview of how emerging technologies may aid diagnosis in the future.Management of Headache in Pregnant Women
https://practicalneurology.com/diseases-diagnoses/headache-pain/management-of-headache-in-pregnant-women/31998/Current recommendations for preventive and acute headache treatments, including off-label options, in pregnant women.Stroke Spotlight: Subarachnoid Hemorrhage and Cerebral Vasospasm
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-spotlight-subarachnoid-hemorrhage-and-cerebral-vasospasm/31524/Cerebral vasospasm increases morbidity and mortality in persons with subarachnoid hemorrhage.Diagnosing and Treating Co-morbid Sleep Apnea in Neurological Disorders, Part II
https://practicalneurology.com/diseases-diagnoses/sleep/diagnosing-and-treating-co-morbid-sleep-apnea-in-neurological-disorders-part-ii/30837/It is crucial for physicians to identify sleep apnea when it co-exists with common neurologic conditions and to be prepared to offer effective interventions.Multiple Sclerosis Minute: Novel Treatment Options for Neuromyelitis Optica Spectrum Disorder
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-novel-treatment-options-for-neuromyelitis-opticaspectrum-disorder/31844/Relapse prevention is critical for preventing the accumulation of disability in NMOSD and new monoclonal antibody therapies are highly effective at doing so.Adult Inflammatory Myopathies: Updates on Classification and Management
https://practicalneurology.com/diseases-diagnoses/neuromuscular/adult-inflammatory-myopathies-updates-on-classification-and-management/32123/The inflammatory myopathies are classified into homogeneous subtypes on the basis of specific autoantibodies, and management strategies continue to evolve rapidly.Dementia Insights: The World Turned Upside Down:
July 2023—A Remarkable Month in the World of Alzheimer Disease Diagnosis and Treatmenthttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-the-world-turned-upside-downbrjuly-2023-a-remarkable-month-in-the-world-of-alzheimer-disease-diagnosis-and-treatment/32075/A review of recent drug approvals, policy changes, and significant studies in the field.- Reimbursement: Chart a Course for Successhttps://practicalneurology.com/columns/practice-management/reimbursement-chart-a-course-for-success/31432/Effective documentation and coding are critical yet challenging aspects of neurology practice, significantly impacting insurance reimbursements. Neurologists often face delays and uncertainties in payments due to the complex and stringent requirements of third-party payers. A single coding error can
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31197/Managing Employee Benefits in Neurological Practices: Balancing Quality and CostIn the evolving landscape of healthcare, neurological practices face increasing challenges in selecting and maintaining employee benefit packages that balance comprehensive coverage with financial sustainability. Physici
Telepresence in Neurology
https://practicalneurology.com/columns/practice-management/telepresence-in-neurology/30389/